New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1214 | 2022 |
Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus J Macías, J Berenguer, MA Japón, JA Girón, A Rivero, LF López‐Cortés, ... Hepatology 50 (4), 1056-1063, 2009 | 318 | 2009 |
Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy JA Pineda, JA García‐García, M Aguilar‐Guisado, MJ Ríos‐Villegas, ... Hepatology 46 (3), 622-630, 2007 | 259 | 2007 |
Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease N Merchante, JA Girón-González, M González-Serrano, J Torre-Cisneros, ... Aids 20 (1), 49-57, 2006 | 242 | 2006 |
The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection S Vergara, J Macías, A Rivero, A Gutiérrez-Valencia, M González-Serrano, ... Clinical infectious diseases 45 (8), 969-974, 2007 | 241 | 2007 |
HCV epidemiology in high-risk groups and the risk of reinfection H Midgard, A Weir, N Palmateer, VL Re III, JA Pineda, J Macías, ... Journal of hepatology 65 (1), S33-S45, 2016 | 230 | 2016 |
Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine J Macías, V Castellano, N Merchante, RB Palacios, JA Mira, C Sáez, ... Aids 18 (5), 767-774, 2004 | 223 | 2004 |
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 214 | 2021 |
Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus JA Pineda, A Caruz, A Rivero, K Neukam, I Salas, A Camacho, P José C, ... Clinical Infectious Diseases 51 (7), 788-795, 2010 | 175 | 2010 |
Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes J Macías, JA Girón-González, M González-Serrano, D Merino, P Cano, ... Gut 55 (3), 409-414, 2006 | 152 | 2006 |
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ... Alzheimer's & Dementia 15 (10), 1333-1347, 2019 | 151 | 2019 |
A common polymorphism in TLR3 confers natural resistance to HIV-1 infection M Sironi, M Biasin, R Cagliani, D Forni, M De Luca, I Saulle, S Lo Caputo, ... The Journal of Immunology 188 (2), 818-823, 2012 | 147 | 2012 |
Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin K Neukam, P Barreiro, J Macías, A Avellón, C Cifuentes, ... Clinical infectious diseases 57 (3), 465-468, 2013 | 141 | 2013 |
High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack J Macías, RB Palacios, E Claro, J Vargas, S Vergara, JA Mira, ... Liver International 28 (6), 781-786, 2008 | 137 | 2008 |
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus–coinfected patients with compensated cirrhosis JA Mira, A Rivero-Juárez, LF López-Cortés, JA Girón-González, F Téllez, ... Clinical Infectious Diseases 56 (11), 1646-1653, 2013 | 113 | 2013 |
Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy J Macias, I Melguizo, F Fernández-Rivera, A Garcia-Garcia, J Mira, ... European Journal of Clinical Microbiology and Infectious Diseases 21, 775-781, 2002 | 113 | 2002 |
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus … J Delgado, J Macias, JA Pineda, JE Corzo, MP Gonzalez-Moreno, ... The American journal of tropical medicine and hygiene 61 (5), 766-769, 1999 | 109 | 1999 |
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus‐coinfected patients with compensated liver cirrhosis N Merchante, A Rivero‐Juárez, F Téllez, D Merino, M José Ríos‐Villegas, ... Hepatology 56 (1), 228-238, 2012 | 108 | 2012 |
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients J Fernandez-Rivera, R Garcia, F Lozano, J Macias, JA Garcia-Garcia, ... HIV Clinical Trials 4 (5), 337-346, 2003 | 104 | 2003 |
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine … JA Mira, LF Lopez-Cortés, P Barreiro, C Tural, M Torres-Tortosa, ... Journal of antimicrobial chemotherapy 62 (6), 1365-1373, 2008 | 93 | 2008 |